Recently, Huang et al. introduced a novel therapeutic strategy for non-small cell lung cancer involving TRAIL-functionalized gold nanoparticles that had a selective cytotoxicity to M2-polarized macrophages [32]. The gene discussed is TNFSF10; the disease is non-small cell lung carcinoma.